Difference between revisions of "BioNLP 2023"

From ACL Wiki
Jump to navigation Jump to search
m
Line 1: Line 1:
 
[[SIGBIOMED]]
 
[[SIGBIOMED]]
  
−
<font size="4"><b>BIONLP 2021 @ NAACL 2021</b></font>
+
<font size="4"><b>BIONLP 2022 @ ACL 2022</b></font>
  
 +
<!-- START -->
 +
 +
===Submission Types & Requirements ===
 +
 +
Following the previous conferences, BioNLP 2022 will be open for two types of submissions: long and short papers. 
 +
Please follow ACL guidelines https://acl-org.github.io/ACLPUB/formatting.html and templates: https://github.com/acl-org/ACLPUB/tree/master/templates
 +
 +
 +
===WORKSHOP OVERVIEW AND SCOPE===
 +
 +
The BioNLP workshop associated with the ACL SIGBIOMED special interest group has established itself as the primary venue for presenting foundational research in language processing for the biological and medical domains. Despite, or maybe due to reaching maturity, the field of Biomedical NLP continues getting stronger.
 +
BioNLP welcomes and encourages inclusion and diversity. BioNLP truly encompasses the breadth of the domain and brings together researchers in bio- and clinical NLP from all over the world. The workshop will continue presenting work on a broad and interesting range of topics in NLP.
 +
 +
BioNLP 2022 will be particularly interested in work on detection and mitigation of bias, BioNLP research in languages other than English, particularly, under-represented languages, and health disparities.
 +
 +
Other active areas of research include, but are not limited to:
 +
* Entity identification and normalization (linking) for a broad range of semantic categories;
 +
* Extraction of complex relations and events;
 +
* Discourse analysis;
 +
* Anaphora/coreference resolution;
 +
* Text mining / Literature based discovery;
 +
* Summarization;
 +
* Τext simplification;
 +
* Question Answering;
 +
* Resources and strategies for system testing and evaluation;
 +
* Infrastructures and pre-trained language models for biomedical NLP / Processing and annotation platforms;
 +
* Development of synthetic data;
 +
* Translating NLP research into practice;
 +
* Getting reproducible results.
 +
 +
<!--
 
===Program ===
 
===Program ===
  
Line 352: Line 383:
 
Please check the website for details on the tasks, datasets, and submission guidelines: https://sites.google.com/view/mediqa2021
 
Please check the website for details on the tasks, datasets, and submission guidelines: https://sites.google.com/view/mediqa2021
  
−
<!-- START -->
+
<!--
−
 
 
−
===Submission Types & Requirements ===
 
−
 
 
−
Following the previous conferences, BioNLP 2021 will be open for two types of submissions: long and short papers.  For the shared task, please select the "long - shared task" submission type.
 
−
Please use tNAACL instructions and templates: https://2021.naacl.org/calls/style-and-formatting/
 
−
The submission site is now available at https://www.softconf.com/naacl2021/bionlp21/
 
−
 
 
 
===Program Committee===
 
===Program Committee===
  
Line 371: Line 395:
 
   * Qingyu Chen, US National Library of Medicine   
 
   * Qingyu Chen, US National Library of Medicine   
 
   * Fenia Christopoulou, National Centre for Text Mining and University of Manchester, UK  
 
   * Fenia Christopoulou, National Centre for Text Mining and University of Manchester, UK  
−
  <!-- * Aaron Cohen, Oregon Health & Science University, USA -->
+
   
 
   * Kevin Bretonnel Cohen, University of Colorado School of Medicine, USA  
 
   * Kevin Bretonnel Cohen, University of Colorado School of Medicine, USA  
 
   * Brian Connolly, Kroger Digital, USA  
 
   * Brian Connolly, Kroger Digital, USA  
Line 395: Line 419:
 
   * Nhung Nguyen, The University of Manchester, UK
 
   * Nhung Nguyen, The University of Manchester, UK
 
   * Karen O'Connor, University of Pennsylvania, USA
 
   * Karen O'Connor, University of Pennsylvania, USA
−
<!--  * Naoaki Okazaki, Tokyo Institute of Technology, Japan -->
 
 
   * Yifan Peng, Cornell Medical School, USA  
 
   * Yifan Peng, Cornell Medical School, USA  
 
   * Laura Plaza, UNED, Madrid, Spain
 
   * Laura Plaza, UNED, Madrid, Spain
Line 412: Line 435:
 
   * Pierre Zweigenbaum, LIMSI - CNRS, France
 
   * Pierre Zweigenbaum, LIMSI - CNRS, France
  
 +
<!--
 
===Shared Task Program Committee===
 
===Shared Task Program Committee===
 
  * Spandana Balumuri, National Institute of Technology Karnataka, Surathkal, India
 
  * Spandana Balumuri, National Institute of Technology Karnataka, Surathkal, India
Line 433: Line 457:
 
  * Shweta Yadav, NLM/NIH
 
  * Shweta Yadav, NLM/NIH
 
  * Yuhao Zhang, Stanford University
 
  * Yuhao Zhang, Stanford University
−
  * Wei Zhu, East China Normal University, Shanghai
+
  * Wei Zhu, East China Normal University, Shanghai -->
−
 
+
earch in languages other than English
−
===WORKSHOP OVERVIEW AND SCOPE===
 
−
 
 
−
The BioNLP workshop associated with the ACL SIGBIOMED special interest group has established itself as the primary venue for presenting foundational research in language processing for the biological and medical domains. Despite, or maybe due to reaching maturity, the field of Biomedical NLP continues getting stronger.
 
−
BioNLP welcomes and encourages inclusion and diversity. BioNLP truly encompasses the breadth of the domain and brings together researchers in bio- and clinical NLP from all over the world. The workshop will continue presenting work on a broad and interesting range of topics in NLP.
 
−
 
 
−
The active areas of research include, but are not limited to:
 
−
* Entity identification and normalization (linking) for a broad range of semantic categories
 
−
* Extraction of complex relations and events
 
−
* Discourse analysis
 
−
* Anaphora/coreference resolution
 
−
* Text mining / Literature based discovery
 
−
* Summarization
 
−
* Question Answering
 
−
* Resources and novel strategies for system testing and evaluation
 
−
* Infrastructures for biomedical text mining / Processing and annotation platforms
 
−
* Translating NLP research to practice
 
−
* Explainable models for biomedical NLP
 
−
* Multi-modal models for biomedical NLP
 
−
* Getting reproducible results
 
−
* BioNLP research in languages other than English
 
  
  

Revision as of 21:27, 20 November 2021

SIGBIOMED 

BIONLP 2022 @ ACL 2022


Submission Types & Requirements

Following the previous conferences, BioNLP 2022 will be open for two types of submissions: long and short papers. Please follow ACL guidelines https://acl-org.github.io/ACLPUB/formatting.html and templates: https://github.com/acl-org/ACLPUB/tree/master/templates


WORKSHOP OVERVIEW AND SCOPE

The BioNLP workshop associated with the ACL SIGBIOMED special interest group has established itself as the primary venue for presenting foundational research in language processing for the biological and medical domains. Despite, or maybe due to reaching maturity, the field of Biomedical NLP continues getting stronger. BioNLP welcomes and encourages inclusion and diversity. BioNLP truly encompasses the breadth of the domain and brings together researchers in bio- and clinical NLP from all over the world. The workshop will continue presenting work on a broad and interesting range of topics in NLP.

BioNLP 2022 will be particularly interested in work on detection and mitigation of bias, BioNLP research in languages other than English, particularly, under-represented languages, and health disparities.

Other active areas of research include, but are not limited to:

  • Entity identification and normalization (linking) for a broad range of semantic categories;
  • Extraction of complex relations and events;
  • Discourse analysis;
  • Anaphora/coreference resolution;
  • Text mining / Literature based discovery;
  • Summarization;
  • Τext simplification;
  • Question Answering;
  • Resources and strategies for system testing and evaluation;
  • Infrastructures and pre-trained language models for biomedical NLP / Processing and annotation platforms;
  • Development of synthetic data;
  • Translating NLP research into practice;
  • Getting reproducible results.

earch in languages other than English


Organizers

  Dina Demner-Fushman, US National Library of Medicine
  Kevin Bretonnel Cohen, University of Colorado School of Medicine
  Sophia Ananiadou, National Centre for Text Mining and University of Manchester, UK
  Jun-ichi Tsujii, National Institute of Advanced Industrial Science and Technology, Japan and University of Manchester, UK


Dual submission policy

Papers may NOT be submitted to the BioNLP 2021 workshop if they are or will be concurrently submitted to another meeting or publication.






Retrieved from "https://aclweb.org/aclwiki/index.php?title=BioNLP_2023&oldid=13255"